Acular (ketorolac tromethamine ophthalmic solution) 0.5%

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved January 1997

Specific Treatments:

Treatment for postoperative inflammation in patients who have undergone cataract extraction

Therapeutic Areas

General Information

Acular has been approved for the treatment of postoperative inflammation in patients who have undergone cataract extraction.